Literature DB >> 17692908

Smoke load/cancer death rate associations in Korea females, 1985-2004.

Hye-Youn Park1, Bruce Leistikow, Alexander Tsodikov, Cheol-In Yoo, Kiyoung Lee.   

Abstract

BACKGROUND: Korea female death rates from many cancers have risen rapidly since 1985. The sources of those cancer death epidemics are unclear but may be related to rising cumulative tobacco smoke damage (smoke load). We assessed Korea female smoke load/cancer death rate associations from 1985 to 2004.
METHODS: Lung cancer rates were used as a smoke load bio-index. Subtracting lung, stomach, and uterine corpus cancer death World age standard rates (rates) from all-sites rates gave us non-lung-stomach-uterine corpus (NLSUc) rates. Lung/NLSUc linear regressions were run, adjusted for autocorrelation. Estimated, lower, and upper bound smoking-attributable fractions (SAFs) were calculated using the formula SAF=1-{(unexposeds' cancer death rate)/(observed rate)}, based on the linear regression and respective best, upper, and lower bound estimated lung, stomach, and uterine cancer death rates in the unexposed.
RESULTS: Lung cancer death rates (smoke load) can explain 88% of the variance in NLSUc rates from 1985 to 2004 after adjusting for autocorrelation. The estimated Korea female all-sites cancer death rate SAF in 2004 was 43% (sensitivity range 29-56%).
CONCLUSIONS: Smoke load, probably from tobacco given the epidemic time course, may cause a large cancer death burden in Korea females despite their very low self-reported prevalence of smoking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17692908     DOI: 10.1016/j.ypmed.2007.06.017

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  1 in total

1.  Male tobacco smoke load and non-lung cancer mortality associations in Massachusetts.

Authors:  Bruce N Leistikow; Zubair Kabir; Gregory N Connolly; Luke Clancy; Hillel R Alpert
Journal:  BMC Cancer       Date:  2008-11-24       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.